SCHEDULE 13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

January 14, 1997

Accession Number

0000899140-97-000081

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →